Drug class

Nitrogen Mustard Derivatives

Nitrogen mustard derivatives are a foundational class of cytotoxic alkylating antineoplastic agents structurally derived from bis-(2-chloroethyl)amines. Read more about Nitrogen Mustard Derivatives

62 drugs in this class 45 manufacturers

Advertisement

Drugs in Nitrogen Mustard Derivatives

Showing 19–27 of 62 drugs

MELPHALAN HCL

NITROGEN MUSTARD DERIVATIVES · MULTIPLE MYELOMA
DR.REDDY'S LAB

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
AMERIGEN PHARMA

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
STI PHARMA, LLC

MELPHALAN HCL

NITROGEN MUSTARD DERIVATIVES · MULTIPLE MYELOMA
FRESENIUS KABI

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
NORTHSTAR RX LL

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
BLUEPOINT LABOR

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
AMNEAL BIOSCIEN

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
CIPLA USA, INC.

CYCLOPHOSPHAMIDE

NITROGEN MUSTARD DERIVATIVES · RETINOBLASTOMA ·+17
Hikma Pharmaceuticals USA
Filter & compare in the drug finder → Opens the drug finder with Nitrogen Mustard Derivatives preselected. Add indication or manufacturer filters there.

About Nitrogen Mustard Derivatives.

Nitrogen mustard derivatives are a foundational class of cytotoxic alkylating antineoplastic agents structurally derived from bis-(2-chloroethyl)amines.

They exert their principal therapeutic effect by forming reactive aziridinium intermediates that covalently bind to DNA bases—chiefly guanine residues—producing intra- and inter-strand cross-links that disrupt replication and transcription, ultimately triggering apoptotic cell death in rapidly dividing cells.

Clinically represented by agents such as cyclophosphamide, chlorambucil, melphalan, ifosfamide, and bendamustine, this class is widely employed in oncology and hematology to treat leukemias, lymphomas, multiple myeloma, and various solid tumors, as well as serving key immunosuppressive roles in conditioning regimens for stem cell transplantation and severe autoimmune disorders.